Table 2

Relationship between total CD24 expression and various clinicopathological factors

CharacteristicAll casesCD24 negativeCD24 positiveP
All carcinomas201 (100%)31 (15.4%)170 (84.6%)
Age at surgery (yr.)0.698
 ≤60105 (100%)15 (14.3%)90 (85.7%)
 >6096 (100%)16 (16.7%)80 (83.3%)
Histological type0.321
 Ductal carcinoma163 (100%)26 (16.0%)137 (84.0%)
 Lobular carcinoma21 (100%)1 (4.8%)20 (95.2%)
pT0.103a
 pT1127 (100%)24 (18.9%)103 (81.1%)
 pT258 (100%)4 (6.9%)54 (93.1%)
 pT3/416 (100%)3 (18.7%)13 (81.3%)
pN0.018
 pN094 (100%)21 (22.3%)73 (77.7%)
 pN1+104 (100%)10 (9.6%)94 (90.4%)
UICC stage0.053a
 I96 (100%)21 (21.9%)75 (78.1%)
 II74 (100%)7 (9.5%)67 (90.5%)
 III31 (100%)3 (9.7%)28 (90.3%)
Histological grade0.445a
Histological grade
 G147 (100%)10 (21.3%)37 (78.7%)
 G2104 (100%)14 (13.5%)90 (86.5%)
 G350 (100%)7 (14%)43 (86%)
Estrogen receptor0.369
 Negative57 (100%)6 (10.5%)51 (89.5%)
 Positive124 (100%)20 (16.1%)104 (83.9%)
c-erbB2 expression0.225
 0, 1+121 (100%)20 (16.5%)101 (83.5%)
 2+, 3+47 (100%)4 (8.5%)43 (91.5%)
  • a χ2 test.